Ohio State Navbar

Research

Ongoing Studies


Ongoing Clinical Research Trials:
              
The Ohio State University Medical Center is a national leader in conducting clinical trials for prevention and treatment of various diseases, which includes diabetes. The Division of Endocrinology, Diabetes and Metabolism and the Diabetes Research Center conduct research for Type 1 and Type 2 diabetes both for NIH and industry sponsored studies.              

For information on the benefits and risks of participating in a clinical research trial, please click here.

The Division of Endocrinology, Diabetes and Metabolism and the DRC are currently enrolling in the following clinical trials. Each study has specific requirements for enrolment. If you are interested in participating in any of the studies, please contact the person listed.


 1. Grifols – We are currently enrolling newly diagnosed Type 1 Diabetic patients (diagnosed within 3 months of screening) ages 16-35. This is a placebo controlled study evaluating the safety and efficacy of four dosing regimens of human plasma-derived alpha – PI. Patients will be reimbursed $50 dollars for all completed clinic visits.

Please contact Angela Howell at 614-688-3785 if interested

2. Pasireotide – Patients with Cushing’s disease and treated with Pasireotide alone and in combination with other therapies will be monitored for 3 years. This is a non-interventional data collection.

Please contact Ashley Mintos at 614-688-6885 in interested

3. Cortendo – An open label study to assess the safety and efficacy of COR-003(Ketoconazole) in patients with Endogenous Cushing’s Syndrome. Subjects will receive $40 for all completed clinic visits.

Please contact Angela Howell at 614-688-3785 if interested.